Lexington, KY, United States of America

Greg A Gerhardt

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Nicholasville, KY (US) (2015 - 2017)
  • Lexington, KY (US) (2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Greg A Gerhardt: Innovator in Neurodegenerative Therapeutics

Introduction

Greg A Gerhardt is a prominent inventor based in Lexington, KY (US), known for his significant contributions to the field of neurodegenerative therapeutics. With a total of five patents to his name, Gerhardt has focused on developing innovative methods and therapeutic peptides aimed at treating various brain disorders.

Latest Patents

Among his latest patents is an anti-neurodegenerative therapeutic that details a method of manufacture and use of therapeutic peptides. These peptides are characterized by the sequence Xaa-Xaa-Xaa-Xaa-Xaa, where Xaa represents an amino acid, specifically proline. The patent also describes a therapeutic peptide that may include a linker to cyclize the peptide. Furthermore, Gerhardt has developed methods for treating neurodegenerative disorders and injuries in human subjects by administering a therapeutically effective amount of these peptides. Another notable patent involves amidated dopamine neuron stimulating peptides, which are designed to treat brain diseases and injuries resulting in dopaminergic deficiencies. These proteins, referred to as amidated glial cell line-derived neurotrophic factor (GDNF) peptides, hold promise for enhancing dopaminergic function in the central nervous system.

Career Highlights

Gerhardt has had a distinguished career, working with reputable organizations such as the University of Kentucky Research Foundation and Amgen Inc. His work has significantly advanced the understanding and treatment of neurodegenerative conditions.

Collaborations

Throughout his career, Gerhardt has collaborated with notable colleagues, including Don Marshall Gash and Luke H Bradley. These partnerships have contributed to the development of innovative therapeutic approaches in neuroscience.

Conclusion

Greg A Gerhardt's work in neurodegenerative therapeutics exemplifies the impact of innovative thinking in medicine. His patents and collaborations continue to pave the way for advancements in treating brain disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…